Designed to support morning alertness, better sleep and mood during darker seasons.
A twenty-minute morning-light session you can wear while making coffee, reading or getting ready.
Why morning light
Properly timed morning light helps tell your body when the day has begun. Research supports its role in morning alertness and in helping the body become ready for sleep at a more consistent time. Separately, established bright-light therapy protocols can improve symptoms of winter-pattern SAD.
OptimRise is designed to make that daily light exposure a simple, repeatable part of your morning.
Built for darker mornings Winter can make morning light harder to get. OptimRise makes the routine wearable, but it has not been clinically evaluated for mood or seasonal affective disorder (SAD) and should not replace a clinician-recommended light box or medical care.
Benefits describe published research on timed light exposure, not tested outcomes for OptimRise. Individual responses vary. See the research and sources.
The indoor morning
Most mornings now begin under a ceiling, not a sky.
Studies of daily light exposure consistently find that indoor electric light is typically far dimmer than outdoor morning light—a difference large enough to affect how the body times its day.
General circadian research, not a claim about OptimRise. Sources and full context on the science page.
The routine
Nothing to schedule, nothing to sit still for. Put them on while moving through what you already do after waking.
Twenty minutes is the intended V1 product setting. Individual responses to light vary, and OptimRise does not measure your circadian phase.
The best routine is the one you’ll actually repeat.
OptimRise is designed around consistency: familiar eyewear, one button and an automatic end to every session. Each decision is weighed against a practical question: will this make tomorrow morning easier?
The product
Final eye-plane optical output remains subject to production-intent measurement and validation. Specifications are development targets, not finished production specifications.
The science
The role of light in circadian timing is well established. OptimRise is designed to make morning exposure easier to repeat.
Read the science foundation and primary sources
This describes general circadian research, not tested outcomes for OptimRise. OptimRise is a consumer wellness product in development. It is not intended to diagnose, treat, cure or prevent any disease, is not FDA-approved or FDA-cleared, and has not completed photobiological safety testing.
Engineering validation
These are real OptimRise engineering-validation units, shown on the bench and in staged product-use settings. They are not finished production products, and the industrial design may change.
No verified eye-plane illuminance figures are published on this site. OptimRise will publish measured values after testing the production-intent optical system.
Founding members
Founding members secure the $199 price, receive a pair from the first production run and get transparent development updates, including changes to the schedule.
$10today, then $189 later
Lock the $199 founding-member price with a fully refundable $10 reservation. Pay the remaining $189 closer to fulfillment.
Reserve for $10Your reservation is applied to the $199 price. The remaining $189 is requested closer to fulfillment and is never charged automatically.
$199in full today
Prefer to pay in full? Pay the complete $199 founding-member price today and owe nothing later.
Preorder in full — $199Pay the complete founding-member price today. Nothing further will be due before shipment.
Estimated shipping: January–March 2027. OptimRise remains in engineering, production and safety validation. All preorder payments are fully refundable until shipment. If the estimated shipping window changes, you may accept the revised window or cancel for a full refund.
Secure checkout is provided by Stripe. The current paid-in-full checkout supports U.S. shipping addresses, with applicable tax calculated at checkout. By continuing, you agree to the Founding Member Preorder Terms and acknowledge the Privacy Notice. This is a product reservation, not a donation or investment.
The founding team
Patrick is a commercial pilot and flight instructor. Aviation treats fatigue and circadian performance as operational realities. That experience led to a simple question: if the biology of morning light is established, why are the products still so difficult to use consistently?
Founder, OptimRise — Chesterfield, Virginia
Stephen leads operations and go-to-market planning for OptimRise. He is helping turn the engineering prototype into a product ready for customers, with a focus on the practical work required to move from validation through launch.
Founding Team — Operations & Go-to-Market
Questions
Clear answers about performance targets, remaining validation and what happens next.
OptimRise is circadian light eyewear designed for everyday mornings. It is being developed to deliver a bounded session of blue-enriched morning light from the upper frame while fitting into an existing morning routine.
OptimRise uses frame-integrated LEDs to deliver blue-enriched light from above the eyes. Light entering the eye participates in the signaling that helps the brain coordinate circadian timing. OptimRise is intended for morning use during activities such as making coffee, reading or getting ready.
Use OptimRise reasonably soon after waking, during your normal indoor morning. OptimRise does not measure your individual circadian phase, and individual responses to light vary.
OptimRise V1 is being designed around an automatic twenty-minute morning session. One button starts the session and the glasses switch off automatically. Twenty minutes is the intended product setting, not a claim that every person has the same biological response.
Final production light output remains subject to optical and safety validation. OptimRise will publish verified eye-plane measurements after testing the production-intent optical system.
OptimRise V1 is targeting a production spectrum near 480 nm, a region of high melanopsin sensitivity. Early EVT optical testing measured a spectral peak near 472 nm. The target and preliminary reading are kept separate until the production-intent spectrum and eye-level output are validated.
OptimRise is currently in Engineering Validation Testing, or EVT. Functioning engineering hardware exists, and the product is being refined toward production with a contract hardware development team. It is not yet a finished production product.
Prescription-lens compatibility is still being finalized during engineering validation. OptimRise will confirm compatibility before collecting a reservation holder's remaining balance. If the production design does not support a customer's needs, the customer may receive a full refund.
OptimRise currently estimates shipping between January and March 2027. This estimate depends on engineering, production and safety validation. If the shipping window changes, customers may accept the revised window or cancel for a full refund.
Your fully refundable $10 reservation locks the $199 founding-member price and is applied to your purchase. The remaining $189 will be requested closer to fulfillment after an updated production status and shipping window are provided. It will not be charged automatically without your separate authorization.
Yes. Founding members may choose to pay the complete $199 preorder price at checkout and owe nothing further before shipment.
Yes. The $10 reservation, the $199 paid-in-full preorder and any later balance payment are fully refundable until shipment. If the estimated shipping window changes, customers may continue waiting or cancel for a full refund.
OptimRise has not completed final photobiological safety testing. Safety testing is part of the remaining validation process and must be completed before shipment. People with eye conditions, medications that increase light sensitivity, or conditions affected by bright light should consult a qualified healthcare professional before use.
OptimRise is designed around category-level research on alertness, sleep and seasonal mood. Properly timed morning light can support wake-time alertness and better sleep by reinforcing circadian timing. Established bright-light therapy protocols can also improve symptoms of winter-pattern SAD. OptimRise itself has not yet been clinically evaluated for alertness, sleep, mood or SAD, so individual outcomes are unknown.
Bright-light therapy is an established treatment for winter-pattern SAD under specific clinical protocols. OptimRise may make morning light easier to fit into a darker-season routine, but it has not been clinically evaluated or FDA-cleared to diagnose, treat, cure or prevent SAD. It should not replace a clinician-recommended light box or medical care. If you think you may have SAD, speak with a qualified healthcare professional.
OptimRise is being developed as a consumer wellness product and is not intended to diagnose, treat, cure or prevent any disease. It is not FDA-approved or FDA-cleared.
Development updates
Get engineering milestones, production updates and any changes to the estimated shipping window. No countdowns. No manufactured urgency.
Contact
Questions about OptimRise, partnerships, press or preorders? We’d be glad to hear from you.
Emails Patrick and copies Stephen.
